Skip to main content
OpenTrials
Completed

NCT Number: NCT05473780

Oxygen Therapy Remote Monitoring in COPD Patients.

Background : Long-term oxygen therapy is prescribed for patients with severe COPD. The aim of oxygen therapy is to administer oxygen at a concentration level higher than that of ambient air, in order to treat or prevent the symptoms and manifestations of arterial hypoxemia; this therapy can be applied either in an acute situation or as a long-term treatment, in cases of stabilized severe chronic hypoxemia.

Currently, pneumologists do not have the possibility, between 2 consultations spaced several months apart, to measure the patient's compliance with the treatment (adherence to oxygen therapy) nor the respect of the prescribed dosage (O2 flow and duration). In addition to the patient's adherence to the treatment, the specialist does not have the possibility to assess the patient's physical activity (walking ...).

This observational study is a e-health, prospective, multicenter study conducted in France under the control of pneumologists.

The main objective of this study is to evaluate the adherence to oxygen therapy in real life, and its evolution, in COPD patients justifying a long term oxygen therapy in stable state.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Obstructive Pulmonary Disease Behavior Chronic Disease Disease Attributes Health Behavior Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Patient Acceptance of Health Care Patient Compliance Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHIAP, Aix-en-Provence, France

Loading trial locations.

About this study

The observational study consists in collecting physiological data (cardiorespiratory and physical activity) and use of the oxygen therapy device in real life during the first months after the initiation of treatment.

For this purpose, two connected medical devices will be provided to each patient during 2 periods of 2 weeks (weeks 6 to 8 then weeks 12 to 14 after the initiation of oxygen therapy). The devices are: 1/ a connected watch that continuously measures vital parameters (heart rate and blood oxygen saturation), and physical activity parameters (no. of steps, distance, duration of effort), and 2/ a Teleox device that remotely monitors patients equipped with an oxygen source (it measures the oxygen flow rate requested by the patient, the duration of use of the oxygen source, and the breathing rate).

Study design: a cohort of 250 patients with COPD newly initiated a long term oxygen therapy will be enrolled in the study and follow-up over 6 months. Data will be collected by lung specialists and home health care provider teams at 2 months, 3.5 months and 6 months post-initiation of oxygen therapy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COPD patients who require the initiation of a long term oxygen therapy.
  • Patient agreeing to use a connected watch and a TeleOx for the remote monitoring of their parameters and physical activity.
  • Non-smoker, ex-smoker, or patient agreeing to stop smoking.
  • Life expectancy greater than 6 months.
  • Signed informed consent form,
  • Subject affiliated to a health insurance system, or is a beneficiary.

Exclusion criteria

  • Patient initiated on oxygen therapy prior to the inclusion visit.
  • Patient with cognitive impairment.
  • Simultaneous participation in a health intervention research,
  • Vulnerable subjects.

Treatment and study plan

Primary outcomes

  1. Assessment of compliance of long term oxygen therapy

    Time frame: 3.5 months

    For each patient, the average daily duration of oxygen use (expressed as numbers of hours of oxygen use per day) will be measured on period of 14 consecutive days at different times after the initiation of oxygen therapy (weeks 6 to 8, and then weeks 12 to 14). The duration of oxygen use is measured using the TeleOx medical device placed in each oxygen source (fixed and portable sources).

Secondary outcomes

  1. Impact of long term oxygen therapy on heart rate

    Time frame: Month 2, Month 3.5

    For each patient, the average and maximum daily heart rate (expressed as beats/minute) will be measured on period of 14 consecutive days at different times after the initiation of oxygen therapy (weeks 6 to 8, and then weeks 12 to 14). The heart rate is measured by the connected watch all along the day.

  2. Impact of long term oxygen therapy on oxygen saturation in the blood (SpO2)

    Time frame: Month 2, Month 3.5

    For each patient, the average nightime and daytime SpO2 (expressed in %) will be calculated by period of 14 consecutive days at different times after the initiation of oxygen therapy (weeks 6 to 8, and then weeks 12 to 14). The SpO2 is measured by the connected watch (automatically at night and manually in day).

  3. Impact of long term oxygen therapy on the respiratory rate

    Time frame: Month 2, Month 3.5

    For each patient, the median, maximum, and 95th percentile daily respiratory rate (expressed in cycles/minute) will be measured on period of 14 consecutive days at different times after the initiation of oxygen therapy (weeks 6 to 8, and then weeks 12 to 14). The respiratory rate is measured using the TeleOx medical device placed in each oxygen source (fixed and portable sources).

  4. Impact of long term oxygen therapy on the physical activity in terms of duration of effort

    Time frame: Month 2, Month 3.5

    For each patient, the total duration of effort per day (expressed in hours) will be measured on period of 14 consecutive days at different times after the initiation of oxygen therapy (weeks 6 to 8, and then weeks 12 to 14). The total duration of effort is measured by the connected watch.

  5. Impact of long term oxygen therapy on the physical activity in terms of duration of number of steps

    Time frame: Month 2, Month 3.5

    For each patient, the total number of steps per day will be measured on period of 14 consecutive days at different times after the initiation of oxygen therapy (weeks 6 to 8, and then weeks 12 to 14). The number of steps is measured by the connected watch.

  6. Impact of long term oxygen therapy on the health related quality of life of COPD patients

    Time frame: At oxygen therapy initiation (baseline), Month 2, Month 3.5

    The quality of life will be assessed using the COPD-specific health related quality of life questionnaire named VQ11.

    The questionnaire VQ11 comprises 11 items distributed across three components (functional: 3 items, psychological: 4 items, social: 4 items). The global score ranges from 11 to 55 points; higher scores mean a better quality of life.

  7. Impact of long term oxygen therapy on the respiratory function

    Time frame: At inclusion, Month 6

    The pulmonologist will assess the evolution of respiratory function according to good medical practice with the pulmonary functional tests. Based on the VEMS/CV value (expressed in %), the pulmonologist judges if the prescribed long term oxygen therapy is sufficient to normalize the respiratory function or if the treatment must be modified.

  8. Assessment of exacerbation

    Time frame: Month 6

    The pulmonologist will assess the number of exacerbation that occured during the first 6-months of long term oxygen therapy.

Sponsors and collaborators

Lead sponsor

Vivisol

Other

Collaborators

  • Slb Pharma

Registry information

Official study title

Observational Study: Oxygen Therapy Monitoring in COPD Patients Using Connected Devices.

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Jul 26, 2022
Registry last updated
Mar 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.